Search for other papers by Marek Niedziela in
Google Scholar
PubMed
target tissues, such as hyperthyroidism, thyrotoxicosis, and Graves’ disease, are given prior to further description of the management of these challenging thyroid states. Hyperthyroidism (in Latin: hyperthyreosis ) is a medical condition in which
Search for other papers by Eng-Loon Tng in
Google Scholar
PubMed
Search for other papers by Yee Sian Tiong in
Google Scholar
PubMed
Search for other papers by Aye Thida Aung in
Google Scholar
PubMed
Search for other papers by Nicole Ya Yuan Chong in
Google Scholar
PubMed
Search for other papers by Zhemin Wang in
Google Scholar
PubMed
Introduction Atrial fibrillation (AF) occurs in 6–28% of people with hyperthyroidism ( 1 , 2 , 3 , 4 , 5 , 6 ). Thyrotoxicosis increases the activities of thrombin, fibrinogen, factor VIII, factor IX, von Willebrand factor, and tissue
Search for other papers by Dimitra Argyro Vassiliadi in
Google Scholar
PubMed
Search for other papers by Ioannis Ilias in
Google Scholar
PubMed
Search for other papers by Maria Pratikaki in
Google Scholar
PubMed
Search for other papers by Edison Jahaj in
Google Scholar
PubMed
Search for other papers by Alice G Vassiliou in
Google Scholar
PubMed
Search for other papers by Maria Detsika in
Google Scholar
PubMed
Search for other papers by Kleio Ampelakiotou in
Google Scholar
PubMed
Search for other papers by Marina Koulenti in
Google Scholar
PubMed
Search for other papers by Konstantinos N Manolopoulos in
Google Scholar
PubMed
Search for other papers by Stamatis Tsipilis in
Google Scholar
PubMed
Search for other papers by Evdokia Gavrielatou in
Google Scholar
PubMed
Search for other papers by Aristidis Diamantopoulos in
Google Scholar
PubMed
Search for other papers by Alexandros Zacharis in
Google Scholar
PubMed
Search for other papers by Nicolaos Athanasiou in
Google Scholar
PubMed
Search for other papers by Stylianos Orfanos in
Google Scholar
PubMed
Search for other papers by Anastasia Kotanidou in
Google Scholar
PubMed
Search for other papers by Stylianos Tsagarakis in
Google Scholar
PubMed
Search for other papers by Ioanna Dimopoulou in
Google Scholar
PubMed
( 5 ). Pathological studies failed to show direct involvement of thyroid tissue ( 6 ). Reports describing patients with thyrotoxicosis attributed to SARS-CoV-2-related subacute thyroiditis ( 7 , 8 , 9 , 10 , 11 , 12 , 13 ) enforced the
Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel
Search for other papers by Amir Bashkin in
Google Scholar
PubMed
Search for other papers by Eliran Yaakobi in
Google Scholar
PubMed
Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel
Search for other papers by Marina Nodelman in
Google Scholar
PubMed
Department of Otolaryngology Head and Neck Surgery, Galilee Medical Center, Nahariya, Israel
Search for other papers by Ohad Ronen in
Google Scholar
PubMed
diagnoses: overt hypothyroidism, subclinical hypothyroidism, overt thyrotoxicosis, subclinical thyrotoxicosis and non-thyroidal illness syndrome (NTIS) and/or effect of drugs. It is impossible to differentiate between the latter two based on thyroid function
Search for other papers by Clara Lundetoft Clausen in
Google Scholar
PubMed
Search for other papers by Åse Krogh Rasmussen in
Google Scholar
PubMed
Search for other papers by Trine Holm Johannsen in
Google Scholar
PubMed
Search for other papers by Linda Maria Hilsted in
Google Scholar
PubMed
Search for other papers by Niels Erik Skakkebæk in
Google Scholar
PubMed
Search for other papers by Pal Bela Szecsi in
Google Scholar
PubMed
Search for other papers by Lise Pedersen in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Thomas Benfield in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Anders Juul in
Google Scholar
PubMed
: overt thyrotoxicosis (TSH < 0.4 mIU/L and free T 4 > 22.0 pmol/L); subclinical thyrotoxicosis (TSH < 0.4 mIU/L and 12.0 ≤ free T 4 ≤ 22.0 pmol/L); overt hypothyroidism (TSH > 4.8 mIU/L and free T 4 < 12.0 pmol/L); subclinical hypothyroidism (TSH > 4
Search for other papers by Alessandro Brancatella in
Google Scholar
PubMed
Search for other papers by Claudio Marcocci in
Google Scholar
PubMed
ongoing risk stratification, considering not only their benefit on outcome of DTC, but also any risk associated with exogenous thyrotoxicosis, namely menopause, osteopenia or osteoporosis, age >60 years, and history of atrial fibrillation ( 17 ) ( Table 1
Search for other papers by Caiyan Mo in
Google Scholar
PubMed
Search for other papers by Tao Tong in
Google Scholar
PubMed
Search for other papers by Ying Guo in
Google Scholar
PubMed
Search for other papers by Zheng Li in
Google Scholar
PubMed
Search for other papers by Liyong Zhong in
Google Scholar
PubMed
levels; and pituitary adenoma diagnosed by contrast-enhanced magnetic resonance imaging (MRI) and confirmed by postoperative pathology as GHPA. The diagnostic criteria of GD included: symptoms and signs of hypermetabolism due to thyrotoxicosis, elevated
Search for other papers by Xichang Wang in
Google Scholar
PubMed
Search for other papers by Xiaochun Teng in
Google Scholar
PubMed
Search for other papers by Chenyan Li in
Google Scholar
PubMed
Search for other papers by Yushu Li in
Google Scholar
PubMed
Search for other papers by Jing Li in
Google Scholar
PubMed
Search for other papers by Weiping Teng in
Google Scholar
PubMed
Search for other papers by Zhongyan Shan in
Google Scholar
PubMed
Search for other papers by Yaxin Lai in
Google Scholar
PubMed
Introduction Thyrotoxicosis refers to a clinical increase in serum thyroid hormones, including hyperthyroidism, thyroid destruction induced by thyroiditis and excessive intake of exogenous thyroid hormone ( 1 ). There are many types of
Search for other papers by Muthiah Subramanian in
Google Scholar
PubMed
Search for other papers by Manu Kurian Baby in
Google Scholar
PubMed
Search for other papers by Krishna G Seshadri in
Google Scholar
PubMed
antithyroid pretreatment on the duration of time needed to achieve cure in patients with the high uptake Graves' thyrotoxicosis who received a fixed dose (15 mCi) of 131 I radioiodine. Materials and methods Subjects We performed a retrospective study of 475
Search for other papers by Waleed K W Al-Badri in
Google Scholar
PubMed
Search for other papers by Hinke Marijke Jellema in
Google Scholar
PubMed
Search for other papers by Arnaud R G G Potvin in
Google Scholar
PubMed
Search for other papers by Ruth M A van Nispen in
Google Scholar
PubMed
Search for other papers by Peter H Bisschop in
Google Scholar
PubMed
Search for other papers by Peerooz Saeed in
Google Scholar
PubMed
Previous prospective studies have generally illustrated an improvement in psychiatric symptoms in hyperthyroid patients after treatment of thyrotoxicosis ( 52 , 53 , 54 , 55 ). The same thing applies to the treatment of Graves’ hyperthyroidism ( 33 , 54